상세 보기
Comparing subcutaneous vs intravenous amivantamab with lazertinib in EGFR-mutated advanced NSCLC: Analysis of Asian patients from PALOMA-3
- Lee, S-H.;
- Akamatsu, H.;
- Yang, J. C-H.;
- Lim, S. M.;
- Liu, B.;
- 외 15명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- Comparing subcutaneous vs intravenous amivantamab with lazertinib in EGFR-mutated advanced NSCLC: Analysis of Asian patients from PALOMA-3
- 저자
- Lee, S-H.; Akamatsu, H.; Yang, J. C-H.; Lim, S. M.; Liu, B.; John, T.; Wang, J.; Ohe, Y.; Kondo, M.; Tamiya, M.; Danchaivijitr, P.; Hsu, P-C.; Zhuo, J.; Saadoun, C.; Saxena, N.; Balaburski, G.; Ribeiro, L.; Gamil, M.; Baig, M.; Cheng, Y.
- 발행일
- 2024-12
- 유형
- Meeting Abstract
- 권
- 35
- 페이지
- S1634 ~ S1634